Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy von ULLOA-MONTOYA, Fernando, LOUAHED, Jamila, BRICHARD, Vincent G, DIZIER, Benjamin, GRUSELLE, Olivier, SPIESSENS, Bart, LEHMANN, Frédéric F, SUCIU, Stefan, KRUIT, Wim H. J, EGGERMONT, Alexander M. M, VANSTEENKISTE, Johan

Volltext

Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results von VANSTEENKISTE, Johan, ZIELINSKI, Marcin, PERDEUS, Jakub, BONNET, Reiner, BASKO, Jazeps, JANILIONIS, Richard, PASSLICK, Bernward, TREASURE, Tom, GILLET, Marc, LEHMANN, Frédéric F, BRICHARD, Vincent G, LINDER, Albert, DAHABREH, Jubrail, GONZALEZ, Emilio E, MALINOWSKI, Wojciech, LOPEZ-BREA, Marta, VANAKESA, Tonu, JASSEM, Jacek, KALOFONOS, Haralabos

Volltext

Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy von Gajewski, Thomas F, Louahed, Jamila, Brichard, Vincent G

Volltext

Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study von Pujol, Jean-Louis, De Pas, Tommaso, Rittmeyer, Achim, Vallières, Eric, Kubisa, Bartosz, Levchenko, Eugeny, Wiesemann, Sebastian, Masters, Gregory A., Shen, Robert, Tjulandin, Sergei A., Hofmann, Hans-Stefan, Vanhoutte, Nicolas, Salaun, Bruno, Debois, Muriel, Jarnjak, Silvija, De Sousa Alves, Pedro Miguel, Louahed, Jamila, Brichard, Vincent G., Lehmann, Frédéric F.

Volltext

GSK's antigen-specific cancer immunotherapy programme: Pilot results leading to Phase III clinical development von Brichard, Vincent G, Lejeune, Diane

Volltext

Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Ca... von KRUIT, Wim H. J, SUCIU, Stefan, BECKER, Juergen C, SPATZ, Alan, EGGERMONT, Alexander M. M, LOUAHED, Jamila, LEHMANN, Frédéric F, BRICHARD, Vincent G, KEILHOLZ, Ulrich, DRENO, Brigitte, MORTIER, Laurent, ROBERT, Caroline, CHIARION-SILENI, Vanna, MAIO, Michele, TESTORI, Alessandro, DORVAL, Thierry, GROB, Jean-Jacques

Volltext

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 tria... von Dreno, Brigitte, Thompson, John F, Smithers, Bernard Mark, Santinami, Mario, Jouary, Thomas, Gutzmer, Ralf, Levchenko, Evgeny, Rutkowski, Piotr, Grob, Jean-Jacques, Korovin, Sergii, Drucis, Kamil, Grange, Florent, Machet, Laurent, Hersey, Peter, Krajsova, Ivana, Testori, Alessandro, Conry, Robert, Guillot, Bernard, Kruit, Wim H J, Demidov, Lev, Thompson, John A, Bondarenko, Igor, Jaroszek, Jaroslaw, Puig, Susana, Cinat, Gabriela, Hauschild, Axel, Goeman, Jelle J, van Houwelingen, Hans C, Ulloa-Montoya, Fernando, Callegaro, Andrea, Dizier, Benjamin, Spiessens, Bart, Debois, Muriel, Brichard, Vincent G, Louahed, Jamila, Therasse, Patrick, Debruyne, Channa, Kirkwood, John M

Volltext

Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology von Michaud, Jean-Philippe, Hallé, Maxime, Lampron, Antoine, Thériault, Peter, Préfontaine, Paul, Filali, Mohammed, Tribout-Jover, Pascale, Lanteigne, Anne-Marie, Jodoin, Rachel, Cluff, Christopher, Brichard, Vincent, Palmantier, Rémi, Pilorget, Anthony, Larocque, Daniel, Rivest, Serge

Volltext

Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung C... von Pujol, Jean-Louis, Vansteenkiste, Johan F., Pas, Tommaso Martino De, Atanackovic, Djordje, Reck, Martin, Thomeer, Michiel, Douillard, Jean-Yves, Fasola, Gianpiero, Potter, Vanessa, Taylor, Paul, Bosquée, Lionel, Scheubel, Robert, Jarnjak, Silvija, Debois, Muriel, de Sousa Alves, Pedro, Louahed, Jamila, Brichard, Vincent G., Lehmann, Frédéric F.

Volltext

A Th1/IFN gamma Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer von Dizier, Benjamin, Callegaro, Andrea, Debois, Muriel, Dreno, Brigitte, Hersey, Peter, Gogas, Helen J., Kirkwood, John M., Vansteenkiste, Johan F., Sequist, Lecia V., Atanackovic, Djordje, Goeman, Jelle, van Houwelingen, Hans, Salceda, Susana, Wang, Fawn, Therasse, Patrick, Debruyne, Channa, Spiessens, Bart, Brichard, Vincent G., Louahed, Jamila, Ulloa-Montoya, Fernando

Volltext

Expression of tumor-associated antigens in breast cancer subtypes von Curigliano, Giuseppe, Bagnardi, Vincenzo, Ghioni, Mariacristina, Louahed, Jamila, Brichard, Vincent, Lehmann, Frederic F., Marra, Antonio, Trapani, Dario, Criscitiello, Carmen, Viale, Giuseppe

Volltext

Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease von Brichard, Vincent G, Lejeune, Diane

Volltext

The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients von Thongprasert, Sumitra, Yang, Pan-Chyr, MD, PhD, Lee, Jung Shin, Soo, Ross, Gruselle, Olivier, Myo, Aung, Louahed, Jamila, Lehmann, Frédéric F, Brichard, Vincent G, Coche, Thierry

Volltext

MAGE-A3-specific anticancer immunotherapy in the clinical practice von Brichard, Vincent G., Godechal, Quentin

Volltext

A Monoclonal Cytolytic T-Lymphocyte Response Observed in a Melanoma Patient Vaccinated with a Tumor-Specific Antigenic Peptide Encoded by Gene MAGE-3 von Coulie, Pierre G., Karanikas, Vaios, Colau, Didier, Lurquin, Christophe, Landry, Claire, Marchand, Marie, Dorval, Thierry, Brichard, Vincent, Boon, Thierry

Volltext

Cancer regression and neurological toxicity cases after anti-MAGE-A3 TCR gene therapy von Brichard, Vincent G, Louahed, Jamila, Clay, Timothy M

Volltext

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE‐3 protein in patients with detectable metastatic melanoma von Kruit, Wim H.J., van Ojik, Heidi H., Brichard, Vincent G., Escudier, Bernard, Dorval, Thierry, Dréno, Brigitte, Patel, Poulam, van Baren, Nicolas, Avril, Marie‐Françoise, Piperno, Sophie, Khammari, Amir, Stas, Marguerite, Ritter, Gerd, Lethé, Bernard, Godelaine, Danièle, Brasseur, Francis, Zhang, Yi, van der Bruggen, Pierre, Boon, Thierry, Eggermont, Alexander M.M., Marchand, Marie

Volltext

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells von VAN BAREN, Nicolas, BONNET, Marie-Claude, ESCUDIER, Bernard, NEGRIER, Sylvie, DIETRICH, Pierre-Yves, MARANINCHI, Dominique, OSANTO, Susanne, MEYER, Ralf G, RITTER, Gerd, MOINGEON, Philippe, TARTAGLIA, Jim, VAN DER BRUGGEN, Pierre, DRENO, Brigitte, COULIE, Pierre G, BOON, Thierry, KHAMMARI, Amir, DORVAL, Thierry, PIPERNO-NEUMANN, Sophie, LIENARD, Danielle, SPEISER, Daniel, MARCHAND, Marie, BRICHARD, Vincent G

Volltext

Immunization With a Recombinant MAGE-A3 Protein After High-dose Therapy for Myeloma von SZMANIA, Susann, GNJATIC, Sacha, OLD, Lloyd J, BARLOGIE, Bart, BRICHARD, Vincent G, VAN RHEE, Frits, TRICOT, Guido, STONE, Katie, FENGHUANG ZHAN, MORENO, Amberly, THURO, Brad, MELENHORST, Jos, BARRETT, John, SHAUGHNESSY, John

Volltext

Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma von WONG, Raymond, LAU, Roy, CHANG, Jenny, KUUS-REICHEL, Tina, BRICHARD, Vincent, BRUCK, Claudine, WEBER, Jeffrey

Volltext